ClassID:

96835

C07K14/28 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)

Recent Application in this class:
#1
20260132173
2026-05-14

MANUFACTURE AND APPLICATION OF FLAGELLIN IMMUNOPOTENTIATING DERIVATIVES WITH TLR5 ACTIVITY USING EUKARYOTIC CELL EXPRESSION SYSTEMS

#2
20260001927
2026-01-01

COMPOSITIONS, FORMULATIONS AND INTERLEUKIN PRODUCTION AND PURIFICATION

#3
20250277005
2025-09-04

METHODS AND COMPOSITIONS RELATED TO THE NEXT GENERATION VACCINE

#4
20250213673
2025-07-03

COMPOSITIONS AND METHODS

#5
20250127888
2025-04-24

Immunogenic Fusion Peptides Including FC Fragment and a Non Toxic B Subunit of AB5 Toxin

#6
20250066439
2025-02-27

RECOMBINANT PROTEINS AND THEIR THERAPEUTIC USES

#7
20240368232
2024-11-07

ANTIVIRAL LARAZOTIDE DERIVATIVES

#8
20240352085
2024-10-24

GENETICALLY MODIFIED PROBIOTICS FOR ORAL DELIVERY OF RENIN-ANGIOTENSIN RELATED THERAPEUTIC PROTEINS AND PEPTIDES

#9
20240285753
2024-08-29

EPITOPE-SCAFFOLD IMMUNOGENS FOR PANCORONAVIRUS VACCINES

#10
20240277837
2024-08-22

DEIMMUNIZED FLAGELLIN AND VACCINE COMPOSITION COMPRISING SAME

#11
20240252610
2024-08-01

A BROADLY PROTECTIVE PROPHYLACTIC VACCINE AGAINST PSEUDOMONAS AERUGINOSA

#12
20240239856
2024-07-18

COMPOSITIONS, FORMULATIONS AND INTERLEUKIN PRODUCTION AND PURIFICATION

#13
20240197853
2024-06-20

MULTIVALENT CHOLERA MULTIEPITOPE FUSION ANTIGEN (MEFA) AND METHODS OF USE

#14
20240058438
2024-02-22

Hepatitis C virus immunogenic compositions and methods of use thereof

#15
20240058433
2024-02-22

COMPOSITIONS AND METHODS

#16
20240024388
2024-01-25

PROBIOTIC COMPOSITIONS AND USES THEREOF

#17
20230338519
2023-10-26

FUSION PROTEIN WITH IMMUNOENHANCING ACTIVITY

#18
20230304023
2023-09-28

BILE SALTS BACTOSENSOR AND USE THEREOF FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES

#19
20230242595
2023-08-03

ADAS COMPRISING BACTERIAL SECRETION SYSTEMS

#20
20230218729
2023-07-13

RECOMBINANT PROTEIN FOR NEUTERING OR SPAYING ANIMAL, AND VACCINE COMPOSITION COMPRISING SAME

#21
20230183720
2023-06-15

ENGINEERED PROTEIN DELIVERY PLATFORM AND USE THEREOF FOR ANTIBACTERIAL TREATMENTS

#22
20230174593
2023-06-08

ARTIFICIALLY LINKED TANDEM ACYL CARRIER PROTEINS TO ENHANCE FATTY ACID PRODUCTION

#23
20230174589
2023-06-08

STRUCTURALLY MODIFIED CHIMERIC POLYPEPTIDE OF HUMAN PAPILLOMAVIRUS, RECOMBINANT PROTEIN COMPRISING SAME POLYPEPTIDE, AND USE OF SAME PROTEIN

#24
20230112697
2023-04-13

METHODS AND COMPOSITIONS RELATED TO THE NEXT GENERATION VACCINE

#25
20230036131
2023-02-02

Genetically modified probiotics for oral delivery of renin-angiotensin related therapeutic proteins and peptides

#26
20230036052
2023-02-02

MODIFIED PROTEIN

#27
20220265804
2022-08-25

FUSION PROTEIN CAPABLE OF SELF-ASSEMBLING INTO PROTEIN NANOPARTICLES AND APPLICATION THEREOF

#28
20220233659
2022-07-28

Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7)-bioencapsulated in plant cells attenuates pulmonary hypertension, cardiac dysfunction and development of autoimmune and experimentally induced ocular disorders

#29
20220153798
2022-05-19

Recombinant proteins and their therapeutic uses

#30
20220112259
2022-04-14

Compositions, formulations and interleukin production and purification

#31
20220089666
2022-03-24

Compositions, formulations and interleukin production and purification

#32
20220054632
2022-02-24

MODIFIED CARRIER PROTEINS FOR O-LINKED GLYCOSYLATION

#33
20220047697
2022-02-17

SALMONELLA VACCINE FOR THE TREATMENT OF CORONAVIRUS

#34
20210285940
2021-09-16

Improved Fluorescent Resonance Energy Transfer-Based Biosensor Proteins And Their Methods of Use Thereof

#35
20210277071
2021-09-09

HYBRID NEUROTOXINS

#36
20210171597
2021-06-10

Compositions, formulations and interleukin production and purification

#37
20210171584
2021-06-10

Cell-free protein synthesis platform derived from cellular extracts of

#38
20210170018
2021-06-10

Hepatitis C virus immunogenic compositions and methods of use thereof

#39
20210145943
2021-05-20

Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7)-bioencapsulated in plant cells attenuates pulmonary hypertension, cardiac dysfunction and development of autoimmune and experimentally induced ocular disorders

#40
20210070814
2021-03-11

Modified protein

#41
20210038708
2021-02-11

Compositions and methods for treating cancer and promoting wound healing

#42
20210009716
2021-01-14

Synthetic proteins and therapeutic uses thereof

#43
20200270313
2020-08-27

COMPOSITIONS AND METHODS FOR SUPPRESSION OF INHIBITOR FORMATION AGAINST COAGULATION FACTORS IN HEMOPHILIA PATIENTS

#44
20200268867
2020-08-27

Biofilm matrix-boosted vaccine

#45
20200255483
2020-08-13

Delivery of structurally diverse polypeptide cargo into mammalian cells by a bacterial toxin

#46
20200173993
2020-06-04

SYNTHETIC HYBRID RECEPTOR AND GENETIC CIRCUIT IN BACTERIA TO DETECT ENTERIC PATHOGENIC MICROORGANISMS

#47
20200140511
2020-05-07

DELIVERY CONSTRUCTS FOR TRANSCYTOSIS AND RELATED METHODS

#48
20200069747
2020-03-05

Probiotic compositions and uses thereof

#49
20200031879
2020-01-30

COMPOSITION COMPRISING RECOMBINANT FUSION PROTEIN OF PATHOGENIC ANTIGEN PROTEIN AND FLAGELLIN OF VIBRIO VULNIFICUS FOR PREVENTING, ALLEVIATING, OR TREATING AGING

#50
20190358304
2019-11-28

Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7)-bioencapsulated in plant cells attenuates pulmonary hypertensions, cardiac dysfunction and development of autoimmune and experimentally induced ocular disorders

#51
20190328860
2019-10-31

Cholera toxin chimera and its use as a staph vaccine

#52
20190315813
2019-10-17

Plasmid-based CTX phage replication system and vibrio cholerae strain that can be infected by CTX phage and can be used for cholera toxin production

#53
20190263878
2019-08-29

Genetically modified probiotics for oral delivery of renin-angiotensin related therapeutic proteins and peptides

#54
20190256609
2019-08-22

Monoclonal antibodies prevent cell surface protein shedding and block tumor growth

#55
20190231867
2019-08-01

Hepatitis C virus immunogenic compositions and methods of use thereof

#56
20190224311
2019-07-25

Adjuvants

#57
20190194265
2019-06-27

Compositions and methods for suppression of inhibitor formation against coagulation factors in hemophilia patients

#58
20190111123
2019-04-18

Compositions and methods for treating cancer and promoting wound healing

#59
20190085036
2019-03-21

Polypeptides Having Immunoactivating Activity And Methods Of Producing The Same

#60
20190077838
2019-03-14

Method for inhibiting, improving, or preventing aging using recombinant fusion protein of pathogenic antigen protein and flagellin of

#61
20180360944
2018-12-20

Process for production of purified recombinant cholera toxin B (rCTB) and formulation thereon

#62
20180353610
2018-12-13

SYSTEMS AND METHODS OF DELIVERY OF BIOACTIVE AGENTS USING BACTERIAL TOXIN-DERIVED TRANSPORT SEQUENCES

#63
20180328923
2018-11-15

Synthetic hybrid receptor and genetic circuit in bacteria to detect enteric pathogenic microorganisms

#64
20180327768
2018-11-15

TARGETED DELIVERY OF THERAPEUTIC PROTEINS BIOENCAPSULATED IN PLANT CELLS TO CELL TYPES OF INTEREST FOR THE TREATMENT OF DISEASE

#65
20180280492
2018-10-04

Cholera toxin chimera and its use as a staph vaccine

#66
20180265553
2018-09-20

Vaccine antigen with increased immunogenicity

#67
20180162917
2018-06-14

Recombinant proteins and their therapeutic uses

#68
20180147273
2018-05-31

METHODS FOR DISPLAYING POLYPEPTIDES AND USES THEREOF

#69
20180118792
2018-05-03

Composition comprising recombinant fusion protein of pathogenic antigen protein and flagellin of vibrio vulnificus for preventing, alleviating, or treating aging

#70
20180099997
2018-04-12

VIBRO-BASED DELIVERY SYSTEM AND IMMUNE SUPPRESSION

#71
20180080033
2018-03-22

Delivery of structurally diverse polypeptide cargo into mammalian cells by a bacterial toxin

#72
20180073031
2018-03-15

Transcriptional sensor for bile acids in bacteroides thetaiotaomicron

#73
20180044384
2018-02-15

METHODS AND COMPOSITIONS TO REDUCE PEANUT-INDUCED ANAPHYLAXIS

#74
20180028638
2018-02-01

Cholera toxin chimera and its use as a staph vaccine

#75
20170283471
2017-10-05

MODIFIED MICROBIAL TOXIN RECEPTOR FOR DELIVERING AGENTS INTO CELLS

#76
20160368951
2016-12-22

Antigen chimera, antigen composition, vaccine, method of preparing the same and cassette thereof

#77
20160367629
2016-12-22

Compositions and methods for delivery of bioencapsulated proteins across blood-brain and retinal barriers

#78
20160362458
2016-12-15

Modified microbial toxin receptor for delivering agents into cells

#79
20160331816
2016-11-17

Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7) bioencapsulated in plant cells attenuates pulmonary hypertension, cardiac dysfunction and development of autoimmune and experimental induced ocular disorders

#80
20160289277
2016-10-06

Compositions and methods for suppression of inhibitor formation against coagulation factors in hemophilia patients

#81
20160213766
2016-07-28

OspA Fusion Protein for Vaccination against Lyme Disease

#82
20160207972
2016-07-21

RECOMBINANT PROTEINS AND THEIR THERAPEUTIC USES

#83
20160175426
2016-06-23

COMPOSITIONS FOR MUCUSAL DELIVERY, USEFUL FOR TREATING PAPILLOMAVIRUS INFECTIONS

#84
20160146827
2016-05-26

Genetically encoded sensors for imaging proteins and their complexes

#85
20160083437
2016-03-24

COMPOSITION COMPRISING RECOMBINANT FUSION PROTEIN OF PATHOGENIC ANTIGEN PROTEIN AND FLAGELLIN OF VIBRIO VULNIFICUS FOR PREVENTING, ALLEVIATING, OR TREATING AGING

#86
20160031947
2016-02-04

Cupredoxin derived transport agents and methods of use thereof

#87
20160017007
2016-01-21

Vibro-based delivery system and immune suppression

#88
20150374780
2015-12-31

Compositions and methods to prevent cancer with cupredoxins

#89
20150361405
2015-12-17

HIGH LEVEL EXPRESSION OF RECOMBINANT TOXIN PROTEINS

#90
20150307546
2015-10-29

THERMO-RESPONSIVE LECTIN-ELP FUSION BINDING LIGANDS FOR GLYCOPROTEIN PURIFICATION BY AFFINITY PRECIPITATION

#91
20150133635
2015-05-14

BACTERIAL TOXIN VACCINE

#92
20150132859
2015-05-14

lipoprotein 15 (Lp15) variants as anti-interference additive in TpN17-based immunoassays for detection of anti-antibodies

#93
20150132334
2015-05-14

Methods for displaying polypeptides and uses thereof

#94
20150125476
2015-05-07

Highly immunogenic peptides derived from the human immunodeficiency virus V2 region

#95
20150017199
2015-01-15

CHOLERA TOXIN CHIMERA AND ITS USE AS A STAPH VACCINE

#96
20150010915
2015-01-08

Crystal structure of the NanR and ManNAc-6P complex, and uses thereof

#97
20140286986
2014-09-25

Polypeptides having immunoactivating activity and methods of producing the same

#98
20140248302
2014-09-04

Recombinant proteins and their therapeutic uses

#99
20140037554
2014-02-06

Cupredoxin derived transport agents and methods of use thereof

#100
20130287804
2013-10-31

Immunogenic polypeptides comprising a modified loop peptide presenting the HIV-1 GP120 3074 mAb epitope and scaffold proteins containing said peptide

#101
20130266607
2013-10-10

Cholera toxin chimera and its use as a staph vaccine

#102
20130230557
2013-09-05

Recombinant microorganisms and uses thereof

#103
20130172229
2013-07-04

Systems and methods of delivery of bioactive agents using bacterial toxin-derived transport sequences

#104
20130156802
2013-06-20

Cholera toxin chimera and its use as a staph vaccine

#105
20130149328
2013-06-13

PLANT-DERIVED CHOLERA AND MALARIA VACCINE

#106
20130084247
2013-04-04

Compositions and methods to prevent cancer with cupredoxins

#107
20130078686
2013-03-28

Production and secretion of fatty acids and fatty acid derivatives

#108
20130078684
2013-03-28

Acyl-ACP wax ester synthases

#109
20130071424
2013-03-21

Peptides mimicking HIV-1 viral epitopes in the V2 loop for the GP120 surface envelope glycoprotein

#110
20130017218
2013-01-17

LIVE BACTERIAL VACCINE SAFETY

#111
20130011338
2013-01-10

Cupredoxin derived transport agents and methods of use thereof

#112
20120322748
2012-12-20

Synthetic peptides that enhance tight junction permeability

#113
20120302509
2012-11-29

Compositions and methods to prevent cancer with cupredoxins

#114
20120238726
2012-09-20

Mutant blue fluorescent protein and method of using the same for fluorescence energy transfer and blue fluorescent fish

#115
20120201855
2012-08-09

Modified flagellin improved toll-like receptor 5 stimulating activity

#116
20120201854
2012-08-09

Modified flagellin improved toll-like receptor 5 stimulating activity

#117
20120135038
2012-05-31

EXPRESSION OF PROTECTIVE ANTIGENS IN TRANSGENIC CHLOROPLASTS AND THE PRODUCTION OF IMPROVED VACCINES

#118
20120128709
2012-05-24

EXPRESSION OF RECOMBINANT PROTEINS

#119
20120122115
2012-05-17

Bacterial quorum sensing biosensor

#120
20110287443
2011-11-24

High level expression of recombinant toxin proteins

#121
20110250342
2011-10-13

PUFA Polyketide Synthase Systems and Uses Thereof

#122
20110250199
2011-10-13

IMMUNOTOXINS AND USES THEREOF

#123
20110231960
2011-09-22

Bacterial toxin vaccine

#124
20110167508
2011-07-07

PUFA POLYKETIDE SYNTHASE SYSTEMS AND USES THEREOF

#125
20110126305
2011-05-26

Mutant blue fluorescent protein and method of using the same for fluorescence resonance energy transfer and blue fluorescent fish

#126
20110008378
2011-01-13

Modified flagellin improved toll-like receptor 5 stimulating activity

#127
20110003734
2011-01-06

Proteins and polynucleotides of

#128
20100304476
2010-12-02

Expression of Human Serum Albumin in Plastids

#129
20100286384
2010-11-11

Replikin peptides in rapid replication of glioma cells and in influenza epidemics

#130
20100286036
2010-11-11

Synthetic peptides that enhance tight junction permeability

#131
20100278860
2010-11-04

System and method for identifying complex patterns of amino acids

#132
20100266640
2010-10-21

Plant-Derived Cholera and Malaria Vaccine

#133
20100256070
2010-10-07

Fusion proteins comprising a fragment of exotoxin A

#134
20100240876
2010-09-23

REPLIKINS AND METHODS OF IDENTIFYING REPLIKIN-CONTAINING SEQUENCES

#135
20100215680
2010-08-26

REPLIKIN PEPTIDES AND ANTIBODIES THEREFOR

#136
20100209355
2010-08-19

Cupredoxin derived transport agents and methods of use thereof

#137
20100099154
2010-04-22

PUFA polyketide synthase systems and uses thereof

#138
20100087377
2010-04-08

Compositions and methods to prevent cancer with cupredoxins

#139
20100055761
2010-03-04

Methods, compositions, and kits for the selective activation of protoxins through combinatorial targeting

#140
20100041753
2010-02-18

INHIBITION OF BIOFILM FORMATION

#141
20100024050
2010-01-28

PUFA polyketide synthase systems and uses thereof

#142
20090324619
2009-12-31

Immunogenic protein carrier containing an antigen presenting cell binding domain and a cysteine-rich domain

#143
20090304733
2009-12-10

Vaccine comprising recombinant ct or lt toxin

#144
20090269333
2009-10-29

REPLIKIN PEPTIDES IN RAPID REPLICATION OF GLIOMA CELLS AND IN INFLUENZA EPIDEMICS

#145
20090191189
2009-07-30

Replikin peptides in rapid replication of glioma cells and in influenza epidemics

#146
20090137778
2009-05-28

REPLIKIN PEPTIDES AND ANTIBODIES THEREFORE

#147
20090104233
2009-04-23

Identification of residues critical for the function of the vibrio cholerae virulence regulator ToxT by scanning alanine mutagenesis

#148
20090098622
2009-04-16

Schizochytrium PKS genes

#149
20090081256
2009-03-26

TRANSGENIC PLANT-BASED VACCINES

#150
20080311144
2008-12-18

Mutant forms of cholera holotoxin as an adjuvant

#151
20080305125
2008-12-11

Mutant forms of EtxB and CtxB and their use as carriers

#152
20080286297
2008-11-20

Chimeric Carrier Molecules for the Production of Mucosal Vaccines

#153
20080275214
2008-11-06

Replikins and methods of identifying replikin-containing sequences

#154
20080226560
2008-09-18

Compositions and methods to prevent cancer with cupredoxins

#155
20080213303
2008-09-04

MUTANT FORMS OF CHOLERA HOLOTOXIN AS AN ADJUVANT

#156
20080148433
2008-06-19

PUFA polyketide synthase systems and uses thereof

#157
20080139471
2008-06-12

Compositions and methods to prevent cancer with cupredoxins

#158
20080113918
2008-05-15

AGONIST POLYPEPTIDE OF RECEPTOR FOR ZOT AND ZONULIN

#159
20080108129
2008-05-08

Method for Obtaining Modified Proteins and Viruses with Intact Native Binding Site

#160
20080107691
2008-05-08

strains VCUSM1 and VCUSM4, method of producing same, and vaccine derivatives thereof

#161
20080050790
2008-02-28

PUFA polyketide synthase systems and uses thereof

#162
20080044873
2008-02-21

PUFA polyketide synthase systems and uses thereof

#163
20080044872
2008-02-21

PUFA polyketide synthase systems and uses thereof

#164
20080044871
2008-02-21

PUFA polyketide synthase systems and uses thereof

#165
20080044870
2008-02-21

PUFA polyketide synthase systems and uses thereof

#166
20080044869
2008-02-21

PUFA polyketide synthase systems and uses thereof

#167
20080044868
2008-02-21

PUFA polyketide synthase systems and uses thereof

#168
20080044867
2008-02-21

PUFA polyketide synthase systems and uses thereof

#169
20080040822
2008-02-14

PUFA polyketide synthase systems and uses thereof

#170
20080038797
2008-02-14

PUFA polyketide synthase systems and uses thereof

#171
20080038796
2008-02-14

PUFA polyketide synthase systems and uses thereof

#172
20080038795
2008-02-14

PUFA polyketide synthase systems and uses thereof

#173
20080038794
2008-02-14

PUFA polyketide synthase systems and uses thereof

#174
20080038793
2008-02-14

PUFA polyketide synthase systems and uses thereof

#175
20080038792
2008-02-14

PUFA polyketide synthase systems and uses thereof

#176
20080038791
2008-02-14

PUFA polyketide synthase systems and uses thereof

#177
20080038790
2008-02-14

PUFA polyketide synthase systems and uses thereof

#178
20080038379
2008-02-14

PUFA POLYKETIDE SYNTHASE SYSTEMS AND USES THEREOF

#179
20080038378
2008-02-14

PUFA POLYKETIDE SYNTHASE SYSTEMS AND USES THEREOF

#180
20080032351
2008-02-07

PUFA polyketide synthase systems and uses thereof

#181
20080026440
2008-01-31

PUFA polyketide synthase systems and uses thereof

#182
20080026439
2008-01-31

PUFA polyketide synthase systems and uses thereof

#183
20080026438
2008-01-31

PUFA polyketide synthase systems and uses thereof

#184
20070264715
2007-11-15

Proteins Involved in Signal Transduction

#185
20070256146
2007-11-01

PUFA polyketide synthase systems and uses thereof

#186
20070212757
2007-09-13

Expression System for the B Subunit of Cholera Toxin

#187
20070185314
2007-08-09

Crystals of LuxP and complexes thereof

#188
20070172517
2007-07-26

Compositions capable of facilitation penetration across a biological barrier

#189
20070141578
2007-06-21

LuxO-sigma54 interactions and methods of use

#190
20070124830
2007-05-31

Plastid genetic engineering via somatic embryogenesis

#191
20070122428
2007-05-31

Mutant forms of cholera holotoxin as an adjuvant

#192
20070116715
2007-05-24

Mutant forms of cholera holotoxin as an adjuvant

#193
20070071775
2007-03-29

Vibrio cholerae with improved biological safety features in freeze dried form

#194
20070053916
2007-03-08

Replikin peptides in rapid replication of glioma cells and in influenza epidemics

#195
20070026009
2007-02-01

Systems and methods for identifying Replikin Scaffolds and uses of said Replikin Scaffolds

#196
20060277635
2006-12-07

Transgenic plant-based vaccines

#197
20060276403
2006-12-07

Agonist polypeptide of receptor for ZOT and zonulin

#198
20060269951
2006-11-30

Inhibitors of autoinducer transporters

#199
20060251713
2006-11-09

Amino acid sequences capable of facilitating penetration across a biological barrier

#200
20060251675
2006-11-09

Mutant cholera holotoxin as an adjuvant and an antigen carrier protein

#201
20060246087
2006-11-02

Hetero type pentamer recombinant vaccine

#202
20060159701
2006-07-20

Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants

#203
20060149037
2006-07-06

Cupredoxin derived transport agents and methods of use thereof

#204
20060117412
2006-06-01

Pharmaceutical proteins, human therapeutics, human serum albumin insulin, native cholera toxic B submitted on transgenic plastids

#205
20060115820
2006-06-01

Primer and probe for detecting vibrio cholerae or vibrio mimicus and detection method using the same

#206
20060099229
2006-05-11

Vibrio cholerae strains VCUSM1 and VCUSM4, method of producing same, and vaccine derivatives thereof

#207
20060057607
2006-03-16

Small RNAs and bacterial strains involved in quorum sensing

#208
20060024669
2006-02-02

System and method for identifying complex patterns of amino acids

#209
20060014290
2006-01-19

Inhibition of biofilm formation

#210
20060002905
2006-01-05

Mutant forms of EtxB and CtxB and their use as carriers

#211
20050273884
2005-12-08

PUFA polyketide synthase systems and uses thereof

#212
20050273883
2005-12-08

Pufa polyketide synthase systems and uses thereof

#213
20050266440
2005-12-01

PUFA polyketide synthase systems and uses thereof

#214
20050241024
2005-10-27

Transgenic plant-based vaccines

#215
20050232938
2005-10-20

Recombinant DNA, plasmid, transformed microorganism and vaccine protein for prevention and therapy of urinary tract infection

#216
20050186219
2005-08-25

Transgenic plant-based vaccines

#217
20050176106
2005-08-11

Use of the RTX secretion system to achieve heterologous polypeptide secretion by

#218
20050176001
2005-08-11

Primers and method of detecting bacteria

#219
20050136103
2005-06-23

Compositions capable of facilitating penetration across a biological barrier

#220
20050136076
2005-06-23

Immunogenic detoxified mutants of cholera toxin

#221
20050130921
2005-06-16

Vibrionaceae replication factors and methods of use thereof

#222
20050108792
2005-05-19

Expression of protective antigens in transgenic chloroplasts

#223
20050106180
2005-05-19

Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants

#224
20050059593
2005-03-17

Agonist polypeptide of receptor for Zot and Zonulin

#225
20050044588
2005-02-24

Methods and substances for preventing and treating autoimmune disease

#226
18885902
2025-06-17

Composition for regulating production of fusion proteins